Full View

Immunobiotics beneficially modulate TLR4 signaling triggered by lipopolysaccharide and reduce hepatic steatosis in vitro

P Kanmani, AZ Ansari, J Villena… - Journal of immunology …, 2019 - Wiley Online Library
Hepatic inflammation and injury may result from the translocation of pathological bacteria
and their proinflammatory mediators. Probiotics attenuate hepatic diseases related to …
被引用次数：19 相关文章

Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro

P Kanmani, AZ Ansari, J Villena, H Kim - Journal of Immunology …, 2019 - go.gale.com
Hepatic inflammation and injury may result from the translocation of pathological bacteria
and their proinflammatory mediators. Probiotics attenuate hepatic diseases related to …

Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro

P Kanmani, AZ Ansari, J Villena, H Kim - Journal of Immunology …, 2019 - cir.nii.ac.jp
抄録< jats: p> Hepatic inflammation and injury may result from the translocation of
pathological bacteria and their proinflammatory mediators. Probiotics attenuate hepatic …

Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro

P Kanmani, AZ Ansari, J Villena… - Journal of Immunology …, 2019 - search.proquest.com
Hepatic inflammation and injury may result from the translocation of pathological bacteria
and their proinflammatory mediators. Probiotics attenuate hepatic diseases related to …

Immunobiotics beneficially modulate TLR4 signaling triggered by lipopolysaccharide and reduce hepatic steatosis in vitro

P Kanmani, AZ Ansari, JC Villena, H Kim - 2019 - notablesdelaciencia.conicet.gov.ar
Hepatic inflammation and injury may result from the translocation of pathological bacteria
and their proinflammatory mediators. Probiotics attenuate hepatic diseases related to …
[PDF] semanticscholar.org

[PDF][PDF] Research Article Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro

P Kanmani, AZ Ansari, J Villena, H Kim - 2019 - pdfs.semanticscholar.org
Hepatic inflammation and injury may result from the translocation of pathological bacteria
and their proinflammatory mediators. Probiotics attenuate hepatic diseases related to …

Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro.

P Kanmani, AZ Ansari, J Villena… - Journal of Immunology …, 2019 - search.ebscohost.com
Hepatic inflammation and injury may result from the translocation of pathological bacteria
and their proinflammatory mediators. Probiotics attenuate hepatic diseases related to …
[HTML] nih.gov

[HTML][HTML] Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro

P Kanmani, AZ Ansari, J Villena… - Journal of Immunology …, 2019 - ncbi.nlm.nih.gov
Hepatic inflammation and injury may result from the translocation of pathological bacteria
and their proinflammatory mediators. Probiotics attenuate hepatic diseases related to …

Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro.

P Kanmani, A Ansari, J Villena, H Kim - Journal of Immunology …, 2019 - europepmc.org
Hepatic inflammation and injury may result from the translocation of pathological bacteria
and their proinflammatory mediators. Probiotics attenuate hepatic diseases related to …

Immunobiotics beneficially modulate TLR4 signaling triggered by lipopolysaccharide and reduce hepatic steatosis in vitro

P Kanmani, AZ Ansari, JC Villena, H Kim - 2019 - ri.conicet.gov.ar
Hepatic inflammation and injury may result from the translocation of pathological bacteria
and their proinflammatory mediators. Probiotics attenuate hepatic diseases related to …